Haemonetics (HAE) Q2 Earnings and Revenues Surpass Estimates

Haemonetics (HAE) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of$ 1.12 per share. This compares to earnings of $1.12 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +13.39%. A quarter ago, it was expected that this provider blood management systems for health care providers and blood collectors would post earnings of$ 1.01 per share when it actually produced earnings of $1.1, deliv ...